MoneyWorks4Me

The company witnessed a 19.96% growth in the revenue at Rs. 11574.00 millions for the quarter ended March 2025 as compared to Rs. 9648.00 millions during the year-ago period.A slim rise of 22.63% was recorded in the Net profit for the quarter ended March 2025 to Rs. 4281.00  millions  From Rs. 3491.00 millions.Operating profit surged to 6233.00 millions from the corresponding previous quarter of 4886.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 11574.00 9648.00 19.96 40945.00 35689.00 14.73 40945.00 35689.00 14.73
Other Income 621.00 359.00 72.98 3213.00 1047.00 206.88 3213.00 1047.00 206.88
PBIDT 6233.00 4886.00 27.57 24656.00 17417.00 41.56 24656.00 17417.00 41.56
Interest 88.00 45.00 95.56 196.00 145.00 35.17 196.00 145.00 35.17
PBDT 6145.00 4841.00 26.94 24460.00 17272.00 41.62 24460.00 17272.00 41.62
Depreciation 937.00 516.00 81.59 2200.00 1719.00 27.98 2200.00 1719.00 27.98
PBT 5208.00 4325.00 20.42 22260.00 15553.00 43.12 22260.00 15553.00 43.12
TAX 927.00 834.00 11.15 3756.00 2487.00 51.03 3756.00 2487.00 51.03
Deferred Tax -67.00 -2.00 3250.00 -319.00 -361.00 -11.63 -319.00 -361.00 -11.63
PAT 4281.00 3491.00 22.63 18504.00 13066.00 41.62 18504.00 13066.00 41.62
Equity 358.00 358.00 0.00 358.00 358.00 0.00 358.00 358.00 0.00
PBIDTM(%) 53.85 50.64 6.34 60.22 48.80 23.39 60.22 48.80 23.39
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..